Drug Markets/DOLUTEGRAVIR SODIUM AND LAMIVUDINE

DOLUTEGRAVIR SODIUM AND LAMIVUDINE

2 NDCs across 1 manufacturers|0 Generic,2 Brand

Total NDCs

0G / 2B

Manufacturers

competing in market

Price Spread

$105.29 – $105.29

7d Activity

2 flat

of 2 total NDCs

Monthly average NADAC price per unit, split by generic and brand

1 manufacturer producing DOLUTEGRAVIR SODIUM AND LAMIVUDINE

2 NDCs total, 2 shown

Drug ↕	NDC	Manufacturer ↕	Price	Market Outlier	Class	7d Change ↕	Therapeutic Class
DOVATO 50-300 MG TABLET	49702024613	ViiV Healthcare Company	$105.2874 per EA	—	Brand	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
DOVATO 50-300 MG TABLET	49702024633	ViiV Healthcare Company	$105.2874 per EA	—	Brand	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor